Based on the Aditxt Inc. stock forecast from 0 analysts, the average analyst target price for Aditxt Inc. is not available over the next 12 months. Aditxt Inc. ’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aditxt Inc. is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Aditxt Inc. ’s stock price was USD 0.32. Aditxt Inc. ’s stock price has changed by -6.89% over the past week, -70.23% over the past month and -99.76% over the last year.
No recent analyst target price found for Aditxt Inc.
No recent average analyst rating found for Aditxt Inc.
Company Overview Aditxt Inc.
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219 Read Less
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor t...Read More
Frequently Asked Questions About Aditxt Inc. (ADTX) Stock
Stock Target Advisor's fundamental analysis for Aditxt Inc. 's stock is Bearish.
Unfortunately we do not have enough data on ADTX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ADTX's stock to indicate what its average analyst target is.
ADTX stock's Price/Earning ratio is -99,999.99.
Our analysis grades ADTX stock's Price / Earning ratio at A. This means that ADTX stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this ADTX may be undervalued for its sector.
The last closing price of ADTX's stock was USD 0.32.
The most recent market capitalization for ADTX is USD 2.96M.
Unfortunately we do not have enough analyst data on ADTX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aditxt Inc. 's stock.
As per our most recent records Aditxt Inc. has 47 Employees.
Aditxt Inc. 's registered address is 737 North Fifth Street, Richmond, VA, United States, 23219.
You can get more information about it from Aditxt Inc. 's website at https://www.aditxt.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative earnings
The company had negative total earnings in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Aditxt Inc. (ADTX) Stock
Stock Target Advisor's fundamental analysis for Aditxt Inc. 's stock is Bearish.
Unfortunately we do not have enough data on ADTX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ADTX's stock to indicate what its average analyst target is.
ADTX stock's Price/Earning ratio is -99,999.99.
Our analysis grades ADTX stock's Price / Earning ratio at A. This means that ADTX stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this ADTX may be undervalued for its sector.
The last closing price of ADTX's stock was USD 0.32.
The most recent market capitalization for ADTX is USD 2.96M.
Unfortunately we do not have enough analyst data on ADTX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Aditxt Inc. 's stock.
As per our most recent records Aditxt Inc. has 47 Employees.
Aditxt Inc. 's registered address is 737 North Fifth Street, Richmond, VA, United States, 23219.
You can get more information about it from Aditxt Inc. 's website at https://www.aditxt.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADTX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
